SiRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells

被引:43
|
作者
Bruun, D [1 ]
Folias, A [1 ]
Akkari, Y [1 ]
Cox, Y [1 ]
Olson, S [1 ]
Moses, R [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
关键词
siRNA; BRCA; 1; BRCA2; Fanconi anemia;
D O I
10.1016/S1568-7864(03)00112-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BRCA1 and BRCA2 proteins act in repair of interstrand crosslinks (ICLs) and maintenance of genome stability and are known to be part of the Fanconi anemia (FA) pathway. We have investigated the role of the BRCA1 and BRCA2 genes in genome stability following ICL damage in normal and FA cells. To circumvent cell lethality of complete disruptions in BRCA1 or BRCA2, small inhibitory RNA (siRNA) was used to transiently deplete the expression of the proteins. Using chromosomal stability after ICL damage as the end point, we find that BRCA1 functions in more than just the FA pathway for genome maintenance, whereas BRCA2 appears to act predominantly in the FA pathway. Depletion of BRCA1 causes a marked decrease, although not a complete absence Of, ubiquitination of FANCD2. In contrast to BRCA1, BRCA2 is not needed for normal ubiquitination of FANCD2 after DNA damage, a requirement for the FA pathway to function. Thus, BRCA2 is epistatic to FA genes for ICL repair, but not for damage-induced modification of FANCD2 and may act downstream form FANCD2. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:1007 / 1013
页数:7
相关论文
共 50 条
  • [41] Targeting BRCA1 and BRCA2 with NEBNext Direct™
    Adams, Scott M.
    Patel, Kruti M.
    Emerman, Amy B.
    Bowman, Sarah K.
    Elfe, Charles D.
    Henig, Noa
    Russello, Salvatore
    Barry, Andrew
    Davis, Theodore
    Hendrickson, Cynthia L.
    CANCER RESEARCH, 2017, 77
  • [42] Oophorectomy in women with BRCA1 or BRCA2 mutations
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
  • [43] The role of BRCA1 and BRCA2 in prostate cancer
    Castro, Elena
    Eeles, Rosalind
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (03) : 409 - 414
  • [44] The role of BRCA1 and BRCA2 in prostate cancer
    Li, Dan
    Kumaraswamy, Easwari
    Harlan-Williams, Lisa M.
    Jensen, Roy A.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1445 - 1459
  • [45] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [46] Inactivation of BRCA1 and BRCA2 in ovarian cancer
    Hilton, JL
    Geisler, JP
    Rathe, JA
    Hattermann-Zogg, MA
    DeYoung, B
    Buller, RE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (18): : 1396 - 1406
  • [47] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [48] Lessons learned from BRCA1 and BRCA2
    Zheng, L
    Li, S
    Boyer, TG
    Lee, WH
    ONCOGENE, 2000, 19 (53) : 6159 - 6175
  • [49] BRCA1 and BRCA2 Mutations and Breast Cancer
    Narod, Steven A.
    Salmena, Leonardo
    DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
  • [50] Characterization of common BRCA1 and BRCA2 variants
    Deffenbaugh, AM
    Frank, TS
    Hoffman, M
    Cannon-Albright, L
    Neuhausen, SL
    GENETIC TESTING, 2002, 6 (02): : 119 - 121